These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill? Wienbergen H; Senges J; Gitt AK Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489 [No Abstract] [Full Text] [Related]
7. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM; Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761 [TBL] [Abstract][Full Text] [Related]
8. [Microalbuminuria in diabetes: setting the points for treatment]. Lehnert H; Klose S; Lobmann R; Zehnder D MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185 [TBL] [Abstract][Full Text] [Related]
9. Drug therapy of hypertension in diabetic patients. Stern N; Tuck M J Hum Hypertens; 1991 Aug; 5(4):295-305. PubMed ID: 1956028 [No Abstract] [Full Text] [Related]
10. [Even at LDL cholesterol 100mg/dl. "Every coronary disease patient has to receive a statin"]. MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963997 [No Abstract] [Full Text] [Related]
11. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
12. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
13. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320 [TBL] [Abstract][Full Text] [Related]
16. [Normalization of blood pressure and lipids in patients with diabetes]. Clemens A; Gallwitz B Med Klin (Munich); 2003 Jul; 98(7):368-76. PubMed ID: 12937902 [TBL] [Abstract][Full Text] [Related]
17. [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin]. Griebenow R Internist (Berl); 2005 Mar; 46(3):350-2. PubMed ID: 15696286 [No Abstract] [Full Text] [Related]
18. Trials and tribulations. Packard CJ Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357 [No Abstract] [Full Text] [Related]
19. [Therapy of hypertension in elderly patients with multiple morbidity]. Slany J Wien Med Wochenschr; 2004; 154 Spec No 1(1):4-6. PubMed ID: 15346545 [No Abstract] [Full Text] [Related]